Panel of Biomarkers Can Distinguish Stable, Exacerbation States in COPD
Artificial neural network model can predict exacerbations at median of seven days before clinical diagnosis
COVID-19, Flu, RSV Vaccine Coverage Low for Nursing Home Residents
As of Nov. 10, 2024, 29.7 percent of nursing home residents had received a 2024 to 2025 COVID-19 vaccine
Heart Failure With Preserved Ejection Fraction Underdiagnosed
Findings seen in patients with severe secondary tricuspid regurgitation of undefined etiology
COVID-19, Flu, RSV Vaccine Coverage Low for Adults in 2024 to 2025 Season
34.7 percent of adults reported having received influenza vaccine; 17.9 percent received COVID-19 vaccine
Studies Examine Cost-Effectiveness of Maternal RSV Vaccination, Nirsevimab in Infants
Seasonal maternal RSV vaccination may be cost-effective, as well as nirsevimab, particularly for those with higher risks
President-Elect Trump Names His Picks to Head the CDC and FDA
In addition, the president-elect has chosen his nominee for surgeon general
Bird Flu Virus in Canadian Teen Shows Mutations That Could Help It Spread Among...
Woman Receives World’s First Robotic Double-Lung Transplant
Optimal Timing of Maternal RSV Vaccine Determined to Be at Least Five Weeks Before...
Maternal vaccination two to three or three to four weeks before delivery linked to lower cord:maternal transfer ratios versus at least five weeks
Study Assesses Risk for 28-Day Hospitalization for Adults With RSV
In three databases, 4.5, 6.0, and 6.2 percent of medically attended RSV patients experienced 28-day all-cause hospitalization
